Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006)

Name: Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006)
License: Public Domain

Juno Therapeutics, a Subsidiary of Celgene

ClinicalTrials.gov · Datasets · License: Public Domain

lymphoma, non-hodgkin, lymphoma, nonhodgkin, lymphoma, b-cell, lymphoma, large b-cell, diffuse

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 290992
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.